Medicare Enrolled
Dr. Michael Favorito, MD
Endocrinology · Wilmington, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Favorito from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Favorito?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Favorito
Dr. Michael Favorito is an endocrinology specialist in Wilmington, NC, with 15 years of NPI registration. Based on federal Medicare data, Dr. Favorito performed 11,402 Medicare services across 4,010 unique beneficiaries.
Between the years covered by Open Payments, Dr. Favorito received a total of $741,849 from 63 pharmaceutical and/or device companies across 2084 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Favorito is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 7% volume in NC
$741,849 industry payments
Medicare Practice Summary
Medicare Utilization ↗11,402
Medicare services
Top 7% in NC for endocrinology
4,010
Unique beneficiaries
$29
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~760 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 6,241 | $18 | $33 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,356 | $86 | $210 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
497 | $8 | $25 |
| Continuous glucose monitoring with interpretation This procedure involves monitoring blood sugar levels in tissue fluid using a sensor placed under the skin, along with the interpretation and reporting of the results. |
477 | $26 | $108 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
409 | $16 | $60 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
344 | $131 | $285 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
323 | $10 | $60 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
289 | $9 | $35 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
227 | $13 | $45 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
211 | $9 | $50 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
169 | $8 | $40 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
164 | $9 | $56 |
| Urine microalbumin test (kidney screening) A laboratory test that measures the amount of microalbumin, a small protein, in a urine sample. This test is used to detect early signs of kidney damage. |
148 | $6 | $20 |
| Creatinine test (kidney function) A blood test that measures the amount of creatinine to assess kidney function or detect muscle injury. |
148 | $5 | $35 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
78 | $29 | $75 |
| Total T3 thyroid hormone test A blood test that measures the total amount of triiodothyronine (T3) hormone in your body. T3 is a thyroid hormone that helps regulate metabolism and energy levels. |
29 | $14 | $99 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
28 | $8 | $25 |
| Free T3 thyroid hormone test A blood test that measures the level of free triiodothyronine (T3) hormone in your body. This helps assess how well your thyroid gland is functioning. |
27 | $17 | $60 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
24 | $70 | $280 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
24 | $24 | $101 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
24 | $116 | $320 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
22 | $14 | $45 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
21 | $34 | $279 |
| Total cortisol level test A blood test that measures the total amount of cortisol hormone in your body. Cortisol is a hormone produced by the adrenal glands. |
20 | $16 | $53 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
19 | $36 | $150 |
| Quadrivalent influenza vaccine, preservative-free A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose. |
18 | $22 | $40 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
18 | $29 | $55 |
| Parathyroid hormone level test A blood test that measures the amount of parathyroid hormone in your body. This hormone helps regulate calcium levels in the blood and bones. |
17 | $40 | $70 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
16 | $7 | $28 |
| Continuous glucose monitoring, tissue fluid This procedure involves continuous monitoring of blood sugar levels in tissue fluid using a sensor placed under the skin. |
14 | $42 | $120 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$741,849
Total received (2018-2024)
Avg $105,978/year across 7 years
Top 2% in NC for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
2,084
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$725,448 (97.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,567 (1.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,834 (0.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$99,862
2023
$109,419
2022
$114,667
2021
$76,731
2020
$75,785
2019
$150,861
2018
$114,526
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$85,741
Novo Nordisk Inc
$12,224
Senseonics, Incorporated
$400
Abbott Laboratories
$260
Boehringer Ingelheim Pharmaceuticals, Inc.
$186
Amgen Inc.
$174
Antares Pharma, Inc.
$128
IBSA Pharma Inc.
$124
Bayer Healthcare Pharmaceuticals Inc.
$93
SANOFI-AVENTIS U.S. LLC
$91
Corcept Therapeutics
$82
Xeris Pharmaceuticals, Inc.
$58
ABBVIE INC.
$51
Kyowa Kirin, Inc.
$45
AstraZeneca Pharmaceuticals LP
$39
Esperion Therapeutics, Inc.
$30
RECORDATI_RARE_DISEASES_INC.
$23
Radius Health, Inc.
$21
Almatica Pharma LLC
$17
Ascendis Pharma Inc
$17
Chiesi USA, Inc.
$16
Astellas Pharma US Inc
$15
Amneal Pharmaceuticals LLC
$14
CeQur Corporation
$13
Top 3 companies account for 98.5% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$558,592
Novo Nordisk Inc
$115,950
Merck Sharp & Dohme Corporation
$29,158
Boehringer Ingelheim Pharmaceuticals, Inc.
$28,618
Amgen Inc.
$1,146
AstraZeneca Pharmaceuticals LP
$938
SANOFI-AVENTIS U.S. LLC
$898
Abbott Laboratories
$801
Tandem Diabetes Care, Inc.
$745
Senseonics, Incorporated
$614
Antares Pharma, Inc.
$417
Radius Health, Inc.
$281
Bayer Healthcare Pharmaceuticals Inc.
$240
Mannkind Corporation
$240
IBSA Pharma Inc.
$228
Corcept Therapeutics
$223
Insulet Corporation
$211
Janssen Pharmaceuticals, Inc
$211
Dexcom, Inc.
$204
ABBVIE INC.
$198
Xeris Pharmaceuticals, Inc.
$153
Shire North American Group Inc
$113
Amarin Pharma Inc.
$112
Amneal Pharmaceuticals LLC
$111
MannKind Corporation
$84
Galderma Laboratories, L.P.
$73
Ascendis Pharma Inc
$72
CeQur Corporation
$69
Regeneron Healthcare Solutions, Inc.
$67
Bayer HealthCare Pharmaceuticals Inc.
$62
Kyowa Kirin, Inc.
$61
Esperion Therapeutics, Inc.
$59
Merck Sharp & Dohme LLC
$58
Horizon Therapeutics plc
$53
Nalpropion Pharmaceuticals LLC
$53
AbbVie, Inc.
$50
Averitas Pharma Inc.
$47
Eisai Inc.
$46
AbbVie Inc.
$44
PFIZER INC.
$43
Ultragenyx Pharmaceutical Inc.
$37
Supernus Pharmaceuticals, Inc.
$36
GRT US Holding, Inc.
$36
Medtronic, Inc.
$31
Astellas Pharma US Inc
$31
EISAI INC.
$29
Takeda Pharmaceuticals U.S.A., Inc.
$26
Kowa Pharmaceuticals America, Inc.
$26
Endo Pharmaceuticals Inc.
$26
Currax Pharmaceuticals LLC
$26
RECORDATI_RARE_DISEASES_INC.
$23
Strongbridge US INC.
$21
Almatica Pharma LLC
$17
VIVUS, Inc.
$17
Boston Scientific Corporation
$17
Amryt Pharma Holdings Ltd
$16
Chiesi USA, Inc.
$16
Clarus Therapeutics Inc.
$14
Horizon Pharma plc
$14
Tolmar, Inc.
$14
Aytu BioScience, Inc
$12
Gilead Sciences, Inc.
$11
Aegerion Pharmaceuticals, Inc.
$11
Top 3 companies account for 94.9% of all-time payments
Associated products mentioned in payments ›
AFREZZA · AVEED · BAQSIMI · BYDUREON · Belviq · CONTRAVE · CeQur Simplicity · Corlanor · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G7 GSS (161) · DIABETES - DISEASE · Dexcom CGM · Dexcom G6 Transmitter · EVENITY · Eversense · FARXIGA · FORTEO · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · FreeStyle Libre Pro · GENERAL PAIN MANAGEMENT · GVOKE HYPOPEN · GVOKE PFS · HUMULIN · HUMULIN U · INTELLIS ADAPTIVESTIM · INVOKANA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LICART · Livalo · MACRILEN · MOUNJARO · MYALEPT · MYCAPSSA · Macrilen · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NOCDURNA · Natesto · OCTRODE · OTREXUP · Omnipod · Otrexup · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Proclaim Family of SCS IPGs · Prolia · QSYMIA · QUTENZA · Qutenza · RAYOS · RECORLEV · RYBELSUS · Repatha · Rybelsus · SCS leads · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMAVERT · STEGLATRO · STEGLUJAN · SYNJARDY · SYNTHROID · Saxenda · Synthroid · TEPEZZA · TERIPARATIDE · TESTOPEL · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UNITHROID · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XYOSTED · Yorvipath · ZEPBOUND · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (98%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in endocrinology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for endocrinology in NC.
Geographic Context
Endocrinologists within 10 mi
8
Per 100K population
3.5
County median income
$72,892
Nearest hospital
WILMINGTON TREATMENT CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Favorito is a clinical cardiology specialist, with above-average Medicare volume (top 7% in NC), with speaking/promotional industry engagement in the top 2% of NC peers, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Favorito experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Favorito performed 6,241 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Favorito receive payments from pharmaceutical companies?
Yes. Dr. Favorito received a total of $741,849 from 63 companies across 2,084 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Favorito's costs compare to other endocrinologists in Wilmington?
Dr. Favorito's average Medicare payment per service is $29. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Favorito) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Wilmington
Browse endocrinologists in Wilmington ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in NC
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in NC
Which NC endocrinologists receive the most from drug and device companies.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Merck Sharp & Dohme Corporation Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology